NASDAQ: NRCNational Research Corp Stock Ownership - Who owns National Research?
Insider buying vs selling
Have National Research Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael D. Hays | Chairman | 2026-01-05 | 9,145 | $15.23 | $139.28kBuy |
| Shane R. Harrison | EVP Chief Financial Officer | 2025-12-29 | 21,271 | $18.66 | $396.92kSell |
| Helen Hrdy | EVP Chief Operating Officer | 2025-12-15 | 12,346 | $15.23 | $188.03kBuy |
| Helen Hrdy | EVP Chief Operating Officer | 2025-12-15 | 11,244 | $17.64 | $198.34kSell |
| Jordan Nicole Freeman | Chief Accounting Officer | 2025-07-31 | 771 | $12.97 | $10.00kBuy |
| Patrick E. Beans | 10% Owner | 2025-05-12 | 2,500 | $13.59 | $33.97kBuy |
NRC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NRC insiders and whales buy or sell their stock.
NRC Shareholders
What type of owners hold National Research Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Property Trust Common | 38.00% | 8,609,601 | $104.00M | Insider |
| Kayne Anderson Rudnick Investment Management LLC | 11.73% | 2,657,828 | $32.11M | Institution |
| Mk Trust Amandla | 8.16% | 1,847,910 | $22.32M | Insider |
| Karen S. Hays | 5.52% | 1,250,000 | $15.10M | Insider |
| Blackrock Inc | 4.44% | 1,005,323 | $12.14M | Institution |
| Morgan Stanley | 4.43% | 1,003,709 | $12.12M | Institution |
| Vanguard Group Inc | 3.67% | 831,379 | $10.04M | Institution |
| Trent S. Green | 2.21% | 500,000 | $6.04M | Insider |
| Dimensional Fund Advisors LP | 2.18% | 494,504 | $5.97M | Institution |
| Geode Capital Management LLC | 1.69% | 383,511 | $4.63M | Institution |
NRC vs Health Information Service Stocks
National Research Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.